エンドトキシン研究　6　より深い理解をめざして

出版社： 医学図書出版
著者：
発行日： 2003-11-10
分野： 医学一般  >  医学一般
ISBN： 4871513203
電子書籍版： 2003-11-10 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

4,400 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

2,200 円(税込)

購入する

商品紹介

第8回日本エンドトキシン研究会の講演内容をまとめた研究会での特別講演、セミナー、シンポジウム、一般演題を集約したものであり、本書は、基礎・臨床を問わず、エンドトキシンの研究に従事している全ての方々の今後の指針およびエンドトキシンの最新の知見がここに収載

目次

  • エンドトキシン研究　6　より深い理解をめざして

    ―目次―

    第1章　特別寄稿

    第2章　エンドトキシンのかかわる自然免疫の基礎研究

    第3章　リピドAの構造とその生物機能

    第4章　エンドトキシンの作用に影響する因子

    第5章　炎症におけるCD14のはたらき

    第6章　臨床病状におけるエンドトキシンとそのレセプター

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

P.8 掲載の参考文献
1) 関口晃一編 : カブトガニの生物学, サイエンスハウス, 1984
 
2) Noguchi H : On the multiplicity of the serum haemagglutinin of cold-blooded animals. Centl f Bakt Ab Orig 34 : 286-288, 1903
 
3) Bang FB : Abacterial disease of Limulus polyphemus. Bull Johns Hopkins Hosp 98 : 323-351, 1956
 
4) Levin J : The history of the development of the Limulus amaebocyte lysate test. In "Bacterial Endotoxin : Structure, Biomedical Significance, and Detection with Limulus Amoebocyte Lysate Test." eds Watson SW, Levin J, Novitzky TJ, Alan R, Liss Inc, New York, 1985, p. 3-28
 
5) Niwa M, Milner KC, Ribi E, et al. : Alteration of physical, chemical, and biological properties of endotoxin by treatment with mild alkali. J Bact 97 : 1069-1077, 1069
 
6) 丹羽允, 和栗修 : カブトガニAmoebocyteの生化学. 生化学, 47 : 1-13, 1975
 
7) 丹羽允 : カブトガニAmoebocyteと内毒素の間のゲル化反応の基礎iと応用. 日細菌誌 30 : 439-449, 1975
 
8) Nakamura S, Iwanaga S, Harada T, et al. : A clottable protein (coagulogen) from amoebocyte lysate of Japanese horseshoe crab (Tachypleus tridentatus). J Biochem 80 : 1011-1021. 1976
PubMed
9) Nakamura S, Morita T, Iwanaga S, et al. : A sensitive substrate from the clotting enzyme in horseshoe crab hemocytes. J Biochem 81 : 1567-1569, 1977
PubMed
10) Iwanaga S, Kawabata S, Muta T : New type of clotting factors and defencee molecules found I horseshoe crab hemolymph : Their structures and functions. J Biochem 123 : 1-15, 1998
 
11) 川畑俊一郎 : カブトガニ異物認識の分子機構. 生体の科学 51 : 187-193, 2000
 
12) Iwanaga S : The moleculer basis of innate immunity in the horseshoe crab. Current Opinion in Immunology 14 : 87-95, 2002
 
13) 山上征二 : 透析液安全基準策定報告. 透析会誌 11 : 1487-1493, 1995
 
14) Yamamoto A, Ochiai M, Kataoka M, et al. : Development of a highly sensitive assay method for biological activity of endotoxin contamination in biological products. Biologicals 30 : 85-92, 2002
PubMed
15) Umeda M, Asakawa M, Terada T, et al. : Adsorption and removal of endotoxin by polymyxin-Sepharose : its properties and application. Jap J Art Organs 12 : 275-278, 1983
 
16) 遠藤重厚, 稲田捷也 : エンドトキシンと病態. へるす出版, 1995, p. 78-88
 
17) 芦田正明 : 昆虫の液性および細胞性生体防御の置けるプロテアーゼカスケード. 生体の科学 51 : 194-201, 2000
 
18) Tuchiya M, Asahi N, Suzuoki F, et al. : Detection of peptidoglycan and β-glycan with silkworm larvae plasma test. FEMS Immunol Med Microbiol 15 : 129-134, 1996
 
19) 岩永貞昭, 大橋邦啓, 丹羽允 : 抗リポ多糖因子の生物学意義. 蛋白質核酸酵素 51 : 100-111, 1986
 
20) Nakamura T, Furunaka H, Miyata T, et al. : Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure. J Biol Chem 263 : 16709-16713, 1988
PubMed
21) Morimoto M, Mori H, Otake T, et al. : Inhibitory effect of tachyplesin I in the proliferation of human immunodeficiency virus in vitro. Chemotherapy 37 : 206-211, 1991
PubMed
22) Tamamura H, Murakami T, Masuda M, et al. : Structure-activity relationship of an anti-HIV peptide, T 22. Biochem Biophys Res Comm 208 : 1729-1735, 1994
 
23) Dankesreiter S, Hoess A, Schneider-Mergener J, et al. : Synthetic endotoxin-binding peptides blocks endotoxin-triggered TNF-α production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock. J Immunol 164 : 4804-4811, 2000
 
24) Noda K, Yamasaki R, Hirooka Y, et al. : Selection of peptides that bind to the core saccharide of R-form Iipopolysaccharide from a phage displayed heptapeptide library. FEMS Microbiol Lett 205 : 349-354, 2000
 
25) Tuchida K, Takemoto Y, Yamagami S, et al. : Detection of peptidoglycan and endotoxin in dialysate using silkworm larvae plasma and limulus amoebocyte lysate methods. Nephron 75 : 438-443, 1997
 
P.16 掲載の参考文献
1) Takano H, Yoshikawa T, Ichinose T, et al. : Diesel exhaust particles enhance antigen-induced airway inflammation and local cytokine expression in mice. Am J Respir Crit Care Med 156 : 36-42, 1997
PubMed
2) Takano H, Ichinose T, Miyabara Y, et al. : Inhalation of diesel exhaust enhances allergen-induced eosinophil recruitment and airway hyperresponsiveness in mice. Toxicol Applied Pharmacol 150 : 328-337, 1998
 
3) Sadakane K, Ichinose T, Takano H, et al. : Murine strain differences in airway inflammation induced by Diesel exhaust particles and house dust mite allergen. Int Arch Allergy Immunol 128 : 220-228, 2002
PubMed
4) Ichinose T, Takano H, Sadakane K, et al. : Differences in airway-inflammation development by house dust mite and diesel exhaust inhalation among mouse strains. Toxicol Applied Pharmacol 187 : 29-37, 2003
 
5) Takano H, Yanagisawa R, Ichinose T, et al. : Diesel exhaust particles enhance lung injury related to bacterial endotoxin through expression of proinflammatory cytokines, chemokines, and ICAM-1. Am J Respir Crit Care Med 165 : 1329-1335, 2002
PubMed
6) Ichinose T, Takano H, Miyabara Y, et al. : Murine strain difference in allergic airway inflammation and immunogloburin production by a combination of antigen and diesel exhaust particles. Toxicology 122 : 183-192, 1997
 
7) Miyabara Y, Yanagisawa R, Takano H, et al. : Murine strain differences in airway inflammation caused by diesel exhaust particles. Eur Respir J 11 : 291-298, 1998
PubMed
8) Miyabara Y, Takano H, Ichinose T, et al. : Diesel exhaust enhances allergic airway inflammation and hyperresponsiveness in mice. Am J Respir Crit Care Med 157 : 1138-1144, 1998
PubMed
9) Takano H, Ichinose T, Miyabara Y, et al. : Diesel exhaust particles enhance airway responsiveness following allergen exposure in mice. Immunopharmacol Immunotoxicol 20 : 329-336, 1998
PubMed
10) Miyabara Y, Ichinose T, Takano H, et al. : Diesel exhaust inhalation enhances airway hyperresponsiveness in mice. Int Arch Allergy Immun 116 : 124-131, 1998
 
11) Miyabara Y, Ichinose T, Takano H, et al. : Effects of diesel exhaust on allergic airway inflammation in mice. J Allergy Clin Immunol 102 : 805-812, 1998
PubMed
12) Ichinose T, Takano H, Miyabara Y, et al. : Long-term exposure to diesel exhaust enhances antigen-induced eosinophilic inflammation and epithelial damage in the murine airway. Toxicol Sciences (Fundam Appl Toxicol) 44 : 70-79, 1998
 
13) Lim HB, Ichinose T, Takano H, et al. : Involvement of superoxide and nitric oxide on airway inflammation and hyperresponsiveness induced by diesel exhaust particles in mice. Free Radic Biol Med 25 (6) : 635-644, 1998
PubMed
14) Arimoto T, Yoshikawa T, Takano H, et al. : Generation of reactive oxygen species and 8-hydroxy-2'-deoxyguanosine formation from diesel exhaust particle components in L 1210 cells. Jpn J Pharmacol 80 : 49-54, 1999
 
15) Takano H, Lim HB, Miyabara Y, et al. : Manipulation of the L-arginine-nitric oxide pathway in airway inflammation induced by diesel exhaust particles in mice. Toxicology 139 : 19-26, 1999
 
16) Hashimoto K, Ishii Y, Takano H, et al. : Exposure to diesel exhaust exacerbates allergen-induced asthmatic responses in guinea pigs. Am J Respir Crit Care Med 164 : 1957-1963, 2001
PubMed
17) Yoshino S, Hayashi H, Takano H, et al. : Effects of diesel exhaust particle extracts on TH l and TH 2 immune response in mice. Int J Immunopathol Pharmacol 15 : 13-18, 2002
 
18) Yoshino S, Hayashi H, Takano H, et al. : Effect of diesel exhaust particle extracts oninduction of oral tolerance in mice. Toxicol Sci 66 : 293-297, 2002
PubMed
19) Takano H, Yanagisawa R, Ichinose T, et al. : Lung expresion of cytchrome P 450 1A1 as a possible biomarker of exposure to diesel exhaust particles. Arch Toxicol 76 : 146-151, 2002
 
20) Ichinose T, Takano H, Miyabara Y, et al. : Diesels exhaust particles enhance antigen-induced eosinophilic inflammation in the airway of mast cell deficient mice. Toxicology 180 : 293-301, 2002
PubMed
21) Sanbongi C, Takano H, Osakabe N, et al. : Rosmarinic acid inhibits lung injury induced by diesel exhaust particles. Free Radic Biol Med 34 : 1060-1069, 2003
PubMed
22) Yanagisawa R, Takano H, Inoue K. et al. : Enhancement of acute lung injury related to bacterial endotoxin by components of diesel exhaust particles. Thorax 58 : 605-612, 2003
PubMed
P.22 掲載の参考文献
1) Hoffmann JA, Kafatos FC, Janeway CA Jr, et al. : Phylogenetic perspectives in innate immunity. Science 288 : 1313-1318, 1999
 
2) Janeway CA Jr : Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp Quant Biol 54 : 1-13, 1989
PubMed
3) Iwanaga S : The molecular basis of innate immunity in the horseshoe crab. Curr Opin Immunol 14 : 87-95, 2002
PubMed
4) 川畑俊一郎, 牟田達史, 三浦芳樹, 他 : カブトガニの生体防御戦略ニディフェンスモレキュルを中心に. "BioDefenseシリーズ 1" 日本生体防御学会編菜根出版, 1996, p63-107
 
5) Osaki T, Okino N, Tokunaga F, et al. : Proline-rich cell surface antigens of horseshoe crab hemocytes are substrates for protein cross-linking with a clotting Protein coagulin. J Biol Chem 277 : 40084-40090, 2002
PubMed
6) Muta T & Iwanaga S : The role of hemolymph coagulation in innate immunity. Curr Opin Immunol 8 : 41-47, 1996
PubMed
7) Solon E, Gupta AP & Gaugler R : Signal transduction during exocytosis in Limulus polyphemus granulocytes. Dev Comp Immunol 20 : 307-321, 1996
PubMed
8) Lemaitre B, Nicolas E, Michaut L, et al. : The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86 : 973-983, 1996
 
9) Medzhitov R, Preston-Hurlburt P & Janeway CA Jr : A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 : 394-397, 1997
PubMed
10) Anderson KV & Nusslein-Volhard C : Information for the dorsal-ventral pattern of the Drosophila embryo is stored as maternal mRNA. Nature 311 : 223-227, 1984
PubMed
11) Ligoxygakis P, Pelte N, Hoffmann JA, et al. : Activation of Drosophila Toll during fungal infection by a blood serine protease. Science 297 : 114-116, 2002
PubMed
12) Kawabata S&Tsuda R : Molecular basis of non-self recognition by the horseshoe crab tachylectins. Biochim Biophys Acta 1572 : 414-421, 2002
PubMed
13) Nagai T & Kawabata S : Alink between blood coagulation and prophenol oxidase activation in arthropod host defense. J Biol Chem 275 : 29264-29267, 2000
 
14) Nagai T, Osaki T&Kawabata S : Functional-conversion of hemocyanin to phenoloxidase by horseshoe crab antimicrobial peptides. J Biol Chem 276 : 27166-27170, 2001
PubMed
P.29 掲載の参考文献
1) Raetz CR, Whitfield C : Lipopolysaccharide endotoxins. Annu Rev Biochem 71 : 635-700, 2002
PubMed
2) Ulevitch RJ, Tobias PS : Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 13 : 437-457, 1995
PubMed
3) Lien E, Chow JC, Hawkins LD, et al. : A novel synthetic acyclic lipid A-like agonist activates cells via the lipopolysaccharide/toll-like receptor 4 signaling Pathway. J Biol Chem 276 : 1873-1880, 2001
PubMed
4) Yu B, Hailman E, Wright SD : Lipopolysaccharide binding protein and soluble CD 14 catalyze exchange of phospholipids. J Clin Invest 99 : 315-324, 1997
 
5) Jack RS, Fan X, Bernheiden M, et al. : Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature 389 : 742-745, 1997
PubMed
6) Wurfel MM, Monks BG, Ingalls RR, et al. : Targeted deletion of the lipopolysaccharide (LPS) -binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact. J Exp Med 186 : 2051-2056, 1997
PubMed
7) Haziot A, Ferrero E, Kontgen F, et al. : Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD 14-deficient mice. Immunity 4 : 407-414, 1996
 
8) Haziot A, Lin XY, Zhang F, et al. : The induction of acute phase proteins by lipopolysaccharide uses a novel pathway that is CD 14-independent. J Immunol 160 : 2570-2572, 1998
 
9) Lemaitre B, Nicolas E, Michaut L, et al. : The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86 : 973-983, 1996
 
10) Medzhitov R, Preston-Hurlburt P, Janeway CA Jr : A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 : 394-397, 1997
PubMed
11) Takeda K, Kaisho T, Akira S : Toll-like receptors. Annu Rev Immunol 21 : 335-376, 2003
PubMed
12) Miyake K, Yamashita Y, Ogata M, et al. : RP 105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J Immunol 154 : 3333-3340, 1995
 
13) Miyake K, Shimazu R, Kondo J, et al. : Mouse MD-1, a molecule that is physically associated with RP 105 and positively regulates its expression. J Immunol 161 : 1348-1353, 1998
 
14) Shimazu R, Akashi S, Ogata H, et al. : MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 189 : 1777-1782, 1999
PubMed
15) Nagai Y, Akashi S, Nagafuku M, et al. : Essential role of MD-2 in LPS responsiveness and TLR 4 distribution. Nat Immunol 3 : 667-672, 2002
 
16) Visintin A, Mazzoni A, Spitzer JA, et al. : Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. PNAS 98 : 12156-12161, 2001
PubMed
17) Kawasaki K, Nogawa H, Nishijima M : Identification of Mouse MD-2 Residues Important for Forming the Cell Surface TLR 4-MD-2 Complex Recognized by Anti-TLR 4-MD-2 Antibodies, and for Conferring LPS and Taxol Responsiveness on Mouse TLR 4 by Alanine-Scanning Mutagenesis. J Immunol 170 : 413-420, 2003
PubMed
18) Akashi S, Nagai Y, Ogata H, et a1. : Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int Immunol 13 : 1595-1599, 2001
 
19) Kawasaki K, Akashi S, Shimazu R : Mouse Toll-like Receptor 4-MD-2 Complex Mediates Lipopolysaccharide-mimetic Signal Transduction by Taxol. J Biol Chem 275 : 2251-2254, 2000
PubMed
20) da Silva Correia J, Ulevitch RJ : MD-2 and TLR 4 N-linked glycosylations are important for a functional lipopolysaccharide receptor. J Biol Chem 277 : 1845-1854, 2001
 
21) Ogata H, Su I-h, Miyake K, et al. : The Toll-like Receptor Protein RP 105 Regulates Lipopolysaccharide Signaling in B Cells. J Exp Med 192 : 23-30, 2000
 
P.35 掲載の参考文献
1) Lemaitre B, Nicolas E, Michaut L, et al. : The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86 : 973-983, 1996
 
2) Chow JC, Young DW, Golenbock DT, et al. : Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274 : 10689-10692, 1999
PubMed
3) Poltorak A, He X, Smirnova I, et al. : Defective LPS signaling in C 3 H/HeJ and C 57 BL/10ScCr mice : mutations in Tlr 4 gene. Science 282 : 2085-2088, 1998
 
4) Qureshi ST, Lariviere L, Leveque G, et al. : Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr 4). JExp Med 189 : 615-625, 1999
 
5) Miyake K, Shimazu R, Kondo J, et al. : Mouse MD-1, a molecule that is physically associated with RP 105 and positively regulates its expression. J Immunol 161 : 1348-1353, 1998
 
6) Shimazu R, Akashi S, Ogata H, et al. : MD-2, amolecule that confers lipopolysaccharide responsiveness on Toll-1ike receptor 4. J Exp Med 189 : 1777-1782, 1999
 
7) Nagai Y, Akashi S, Nagafuku M, et al. : Essential role of MD-2 in LPS responsiveness and TLR 4 distribution. Nat Immunol 3 : 667-672, 2002
 
8) da Silva CJ, Soldau K, Christen U, et al. : Lipopolysaccharide is in Close Proximity to Each of the Proteins in Its Membrane Receptor Complex : Transfer from CD 14 to TLR 4 and MD-2. J Biol Chem 276 : 21129-21135, 2001
 
9) Viriyakosol S, Tobias PS, Kitchens RL, et al. : MD-2 binds to bacterial lipopolysaccharide. J Biol Chem 276 : 38044-38051, 2001
PubMed
10) Akashi S, Nagai Y, Ogata H, et al. : Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int Immuno113 : 1595-1599, 2001
PubMed
11) Muroi M, Ohnishi T, Tanamoto K : MD-2, a Novel Accessory Molecule, Is Involved in Species-Specific Actions of Salmonella Lipid A. Infect Immun 70 : 3546-3550, 2002
PubMed
12) da Silva CJ, Ulevitch RJ : MD-2 and TLR 4 N-linked glycosylations are important for a functional lipopolysaccharide receptor. J Biol Chem 277 : 1845-1854, 2002
 
P.41 掲載の参考文献
1) Yasuda H, Shima N, Nakagawa N, et al. : Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95 : 3597-3602, 1998
PubMed
2) Wong BR, Josien R, Lee Sy, et al. : The TRAF family of signal transducers mediates NF-κB activation by the TRANCE receptor. J Biol Chem 273 : 28355-28359, 1997
 
3) Anderson DM, Maraskovsky E, Billingsley WL, et al. : A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390 : 175-179, 1997
PubMed
4) Suda T, Takahashi N, Udagawa N, et al. : Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20 : 345-357, 1999
PubMed
5) Tsuda E, Goto M, Mochizuki S, et al. : Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 234 : 137-142, 1997
PubMed
6) Simonet WS, Lacey DL, Dunstan CR, et al. : Osteoprotegerin : a novel secreted protein involved in the regulation of bone density. Cell 89 : 309-319, 1997
PubMed
7) Takami M, Takahashi N, Udagawa N, et al. : Intracellular calcium and protein kinase C mediate expression of receptor activator of NF-κB ligand and osteoprotegerin in osteoblatsts. Endocrinology 141 : 4711-4719, 2000
 
8) Jimi E, Akiyama S, Tsurukai T, et al. : Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol 163 : 434-442, 1999
PubMed
9) Kobayashi K, Takahashi N, Jimi E, et al. : Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 191 : 275-286, 2000
PubMed
10) Azuma Y, Kaji K, Katogi R, et al. : Tumor necrosis factor-α induces differentiation of and bone resorption by osteoclasts. J Biol Chem 275 : 4858-4864, 2000
 
11) Jimi E, Nakamura I, Duong L, et al. : Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp Cell Res 247 : 84-93, 1999
PubMed
12) Inoue J, Ishida T, Tsukamoto N, et al. : Tumor necrosis factor receptor-associated factor (TRAF) family : adapter proteins that mediate cytokine signaling. Exp Cell Res 254 : 14-24, 2000
PubMed
13) Lomaga MA, Yeh WC, Sarosi I, et al. : TRAF 6 deficiency results in osteopetrosis and defective interleukin-1, CD 40, and LPS signaling, Genes Dev 13 : 1015-1024, 1999
 
14) Naito A, Azuma S, Tanaka S, et al. : Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF 6-deficient mice. Genes Cells 4 : 353-362, 1999
 
15) Akira S, Takeda K, Kaisho T : Toll-like receptors : critical proteins linking innate and acquired immunity. Nat Immunol 2 : 675-680, 2001
PubMed
16) Yamamoto M, Sato S, Hemmi H, et al. : Essential role for TIRAP in activation of the signalling cascade shared by TLR 2 and TLR 4. Nature 420 : 324-329, 2002
 
17) Suda K, Udagawa N, Takami M, et al. : Lipopolysaccharide stimulates osteoclast promotion via RANKL expression independent of PGE2 production. In preparation
 
18) Takami M, Kim N, Rho J, et al. : Stimulation by toll-like receptors inhibits osteoclast differentiation. J Immunol 169 : 1516-23, 2000
 
19) Li X, Udagawa N, Itoh K, et al. : p38 MAP kinase-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology 143 : 3105-3113, 2002
 
20) Suda K, Woo JT, Takami M, et al. : Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-α, IL-1, and RANKL. J Cell Physiol 190 : 101-108, 2000
 
21) Itoh K, Udagawa N, Kobayashi K, et al. : LPS promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to LPS is different from that of macrophages. J Immunol 170 : 3688-3695, 2003
PubMed
P.51 掲載の参考文献
1) Imoto M, Yoshimura H, Shimamoto T, et al. : Total synthesis of Escherichia coli lipid A, the endotoxically active principle of cell-surface lipopolysaccharide. Bull Chem Soc Jpn 60 : 2205-2214, 1987
 
2) Loppnow H, Brade H, Duerrbaum I, et al. : IL-1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol 142 : 3229-3238, 1989
PubMed
3) Yang H, Daun J M, Rose J R, et al. : Examination of chlorpromazine and other amphipathic drugs on the activity of lipopolysaccharide antagonists, E 5564 and E 5531. J Endotoxin Res 6 : 447-452, 2000
 
4) Lien E, Means T K, Heine H, et al. : Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 105 : 497-504, 2000
PubMed
5) Akashi S, Nagai Y, Ogata H, et al. : Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int Immunol 13 : 1595-1599, 2001
PubMed
6) Lee H K, Lee J, Tobias P S : Two lipoproteins extracted from Escherichia coli K-12 LCD 25 lipopolysaccharide are the major components responsible for Toll-like receptor 2-mediated signaling. J Immunol 168 : 4012-4017, 2002
 
7) Liu W-C, Oikawa M, Fukase K, et al. : A Divergent Synthesis of Lipid A and Its Chemically Stable Unnatural Analogues. Bull Chem Soc Jpn 72 : 1377-1385, 1999
 
8) Kusama T, Soga T, Shioya E, et al. : Synthesis and antitumor activity of lipid A analogs having a phosphonooxyethyl group with α- or β-configuration at position 1. Chem Pharm Bull 38 : 3366-3372, 1990
 
9) Fukase K, Ueno A, Fukase Y, et al. : Synthesis and biological activities of lipid A analogs possessing β-glycosidic linkage at 1-position. Bull Chem Soc Jpn 76 : 485-500, 2003
 
10) Takayama K, Din Z Z, Mukerjee P, et al. : Physicochemical properties of the lipopolysaccharide unit that activates B lymphocytes. J Biol Chem 265 : 14023-14029, 1990
PubMed
11) Fukase K, Fukase Y, Oikawa M, et al. : Divergent synthesis and biological activities of lipid Aanalogs of shorter acyl chains. Tetrahedron 54 : 4033-4050, 1998
 
12) Fukase K, Oikawa M, Suda Y, et al. : New synthesis and conformational analysis of lipid A : biological activity and supramolecular assembly. J Endotoxin Res 5 : 46-51, 1999
 
13) Fukase Y, Zhang S-Q, Iseki K, et al. : New efficient route for synthesis of lipid A by using affinity separation. Synlett : 1693-1698, 2001
 
14) Fukase Y, Fukase K, Kusumoto S : Propargyloxycarbonyl and propargyl groups for protection of amino, hydroxy, and carboxy functions. Peptide Science 1999 : 93-96, 2000
 
15) Iida-Tanaka N, Fukase K, Utsumi H, et al. : Conformational studies on a unique bis-sulfated glycolipid using NMR spectroscopy and molecular dynamics simulations. Eur J Biochem 267 : 6790-6797, 2000
PubMed
16) Ferguson A D, Hofmann E, Coulton J W, et al. : Siderophore-mediated iron transport : crystal structure of FhuA with bound lipopolysaccharide. Science 282 : 2215-2220, 1998
PubMed
17) Seydel U, Oikawa M, Fukase K, et al. : Intrinsic conformation of lipid A is responsible for agonistic and antagonistic activity. Eur J Biochem 267 : 3032-3039, 2000
PubMed
18) Hawkins L D, Ishizaka S T, McGuinness P, et al. : A novel class of endotoxin receptor agonists with simplified structure, toll-like receptor 4-dependent immunostimulatory action, and adjuvant activity. J pharmacol Exp Ther 300 : 655-661, 2002
PubMed
19) Gomi K, Kawasaki K, Kawai Y, et al. : Toll-like receptor 4-MD-2 complex mediates the signal transduction induced by flavolipin, an amino acid-containing lipid unique to Flavobacterium meningosepticum. J Immunol 168 : 2939-2943, 2002
PubMed
P.57 掲載の参考文献
1) Slots J, Listgarten MA : Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases. J Clin Periodontol 15 : 85-93, 1988
PubMed
2) Ogawa T : Immunobiological properties of chemically defined lipid A from lipopolysaccaride of Porphyromonas (Bacteroides) gingivalis. Eur J Biochem 219 : 737-742, 1994
 
3) Ogawa T, Uchida H, Amino K : Immunobiological activities of chemically defined lipid A from lipopolysaccharides of Porphyromonas gingivalis. Microbiology 140 : 1209-1216, 1994
PubMed
4) Lindberg AA, Weintraub A, Zahringer U, et al. : Structure-activity relationships in lipopolysaccharides of Bacteroides fragilis. Rev Infect Dis 12 : S133-141, 1990
PubMed
5) Iki K, Kawahara K, Sawamura S, et al. : A novel component different from endotoxin extracted from prevotella intemaedin ATCC 25611 activates lymphoid cells from C 3 H/HeJ mice and gingival fibroblasts from humans. Infect Immun 65 : 4531-4538, 1997
 
6) Kirikae T, Nitta T, Kirikae F, et al. : Lipopolysaccharides (LPS) of oral black-pigmented bacteria induce tumor necrosis factor production by LPS-refractory C3H/HeJ macrophages in a way different from that of Salmonella LPS. Infect Immun 67 : 1736-1742, 1999.
 
7) Ogawa T, Shimauchi H, Uchida H, et al. : Stimulation of splenocytes in C 3 H/HeJ mice with Poiphyromonczs gingivalis lipid A in comparison with enterobacterial lipid A. Immunobiology 196 : 399-414, 1996
 
8) Shimauchi H, Ogawa T, Uchida H, et al. : Splenic B-cell activation in lipopolysaccharide-non-responsive C 3 H/HeJ mice by lipopolysaccharide of Porphyromonas gingivalis. Experientia 52 : 909-917, 1996
 
9) Ogawa T : Chemical structure of lipid A from Porphyromonas (Bacteroides) gingivalis lipopolysaccharide. FEBS Lett 332 : 197-201, 1993
PubMed
10) Ogawa T, Asai Y, Yamamoto H, et a1. : Immunobiological activities of a chemically synthesized lipid A of Porphyromonas gingivaliss. FEMS Immunol Med Microbiol 28 : 273-281, 2000
 
11) Medzhitov R : Toll-like receptors and innate immunity. Nature Rev Immunol 1 : 135-145, 2001
 
12) Akira S, Hoshino K, Kaisho T : The role of Toll-like receptors and MyD 88 in innate immune responses. J Endotoxin Res 6 : 383-387, 2000
 
13) Hoshino K, Takeuchi O, Kawai T, et al. : Toll-Like receptor 4 (TLR 4) -deficient mice are hyporesponsive to lipopolysaccharide : evidence for TLR 4 as the Lps gene product. J Immunol 162 : 3749-3752, 1999
 
14) Poltorak A, He X, Smirnova I, et al. : Defective LPS signaling in C 3 H/HeJ and C 57 BL/10ScCr mice : mutations in Tlr 4 gene. Science 282 : 2085-2088, 1998
 
15) Shimazu R, Akashi S, Ogata, H et al. : MD-2, amolecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 189 : 1777-1782, 1999
 
16) Yang RB, Mark MR, Gray A, et al. : Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395 : 284-288, 1998
PubMed
17) Hirschfeld M, Ma Y, Weis JH, et al. : Repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J Immunol 165 : 618-622, 2000
PubMed
18) Takeuchi O, Hoshino K, Kawai T, et al. : Differential roles of TLR 2 and TLR 4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11 : 443-451, 1999
PubMed
19) Aliprantis AO, Yang RB, Mark MR, et al. : Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285 : 736-739, 1999
PubMed
20) Underhill DM, Ozinsky A, Hajjar AM, et al. : The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens, Nature 401 : 811-815, 1999
PubMed
21) Hirschfeld M, Weis JJ, Toshchakov V, et al. : Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 69 : 1477-1482, 2001
PubMed
22) Takeuchi O, Takeda K, Hoshino K, et al. : Cellular responses to bacterial cell wall components are mediated through MyD 88-dependent signaling cascades. Int Immunol 12 : 113-117, 2000
 
23) Ogawa T, Asai Y, Hashimoto M, et al. : Cell activation by Porphyromonas gingivalis lipid A molecule through Toll-like receptor 4- and myeloid differentiation factor 88-dependent signaling pathway. Int Immunol 14 : 1325-1332, 2002
PubMed
P.70 掲載の参考文献
1) Kawahara K, Tsukano H, Watanabe H, et al. : Modification of the structure and activity of lipid A in Ye rsin ia pestis lipopolysaccharide by growth temperature. Infect Immun 70 : 4092-4098, 2002
 
2) Takada H, Kotani S : Muramyl dipeptide and derivatives. In "The Theory and Practical Application of Adjuvant", ed Stewart-Tull DES, John Wiley&Sons, Chichester, 1995, p171-202
 
2) 川原一芳, 塚野尋子, 渡辺治雄 : Yersinia Pestisリポ多糖コア糖鎖の化学構造. 日本細菌学雑誌 57 (第75回日本細菌学会要旨集) : 85, 2002
 
3) Akira S, Takeda K, Kaisho T : Toll-like receptors : critical proteins linking innate and acquired immunity. Nat Immunol 2 : 675-680, 2001
PubMed
3) Bibel D J, and Chen T H : Diagnosis of plague : an analysis of the Yersin-Kitasato controversy. Bacteriol Rev 40 : 633-651, 1976
 
4) Yoshimura A, Takada H, Kaneko T, et al. : Structual requirements of muramylpeptides for induction of Toll-like receptor 2-mediated NF-κB activation in CHO cells. J Endotoxin Res 6 : 407-410, 2000
 
4) Ibrahim A, Goebel B M, Liesack W, et al. : The phylogeny of the genus Yersinia based on 16SrRNA sequences. FEMS Microbiol Lett 114 : 173-177, 1993
 
5) Achtman M, Zurth K, Morelli G, et al. : Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc Natl Acad Sci USA 96 : 14043-14048, 1999
PubMed
5) Vidal VF, Casteran N, Riendeau CJ, et al. : Macrophage stimulation with Murabutide, an HIV-suppressive muramyl peptide derivative, selectively activates extracellular signalregulated kinases 1 and 2, C/EBPβ and STAT 1 : role of CD 14 and Toll-like receptors 2 and 4. Eur J Immunol 31 : 1962-1971, 2001
 
6) Asai Y, Ohyama Y, Gen K, et al. : Bacterial fimbriae and their peptides activate human gingival epithelial cells through Toll-like receptor 2. Infect Immun 69 : 7387-7395, 2001
PubMed
6) Skurnik M, Peippo A, and Ervela E : Characterization of the O-antigen gene clusters of Yersinia pseudotuberculosis and the cryptic Oantigen gene cluster of Yersinia pestis shows that the plague bacillus is most closely related to and has evolved from Y. pseudotuberculosis serotype O : 1b. Mol Microbiol 37 : 316-330, 2000
PubMed
7) Chart H, Cheasty T, and Rowe B : Differentiation of Yersinia pestis and Y. pseudotuberculosis by SDS-PAGE analysis of lipopolysaccharide. Lett Appl Microbiol 20 : 369-370, 1995
PubMed
7) Yang S, Tamai R, Akashi S, et al. : Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect Immun 69 : 2025-2030, 2001
PubMed
8) Darveau R P, Charnetzky W T, Hurlbert R E, et al. : Effects of growth temperature, 47-megadalton plasmid, and calcium deficiency on the outer membrane protein porin and lipopolysaccharide composition of Yersinia pestis EV76. Infect Immun 42 : 1092-1101, 1983
 
8) Takada H, Yang S, Yokoyama S : Enhancement of endotoxin activity by muramyldipeptide. J Endotoxin Res 8 : 337-342, 2002
PubMed
9) Ribi EE, Cantrell JL, Von Eschen KB, et al. : Enhancement of endotoxic shock by 2Vacetylmuramyl-L-alanyl - (L-seryl) -D-isog1utamine (muramyl dipeptide). Cancer Res 39 : 4756-4759, 1979
PubMed
9) Prior J L, Parkhill J, Hitchen P G, et al. : The failure of different strains of Yersinia pestis to produce lipopolysaccharide O-antigen under different growth condition is due to mutations in the O-antigen gene cluster. FEMS Microbiol Lett 197 : 229-233, 2001
PubMed
10) Chedid LA, Parant MA, Audibert FM, et al. : Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity. Infect Immun 35 : 417-424, 1982
PubMed
10) Hartley J L, Adams G A, and Tornabene T G : Chemical and physical properties of lipopolysaccharide of Yersinia pestis. J Bacteriol 118 : 848-854, 1974
PubMed
11) Aussel L, Therisod H, Karibian D, et al. : Novel variation of lipid A structures in strains of different Ye rsin ia species. FEBS Lett 465 : 87-92, 2000
 
11) Bloksma N, Hofhuis FMA, Willers JMN : Endotoxin-induced antitumor activity in the mouse is highly potentiated by muramyl dipeptide. Cancer Lett 23 : 159-165, 1984
 
12) Bengoechea J, Brandenburg K, Seydel U, et al. : Yersinia pseudotzaberculosis and Yersinia pestis show increased outer membrane permeability to hydrophobic agents which correlates with lipopolysaccharide acyl-chain fluidity. Microbiology 144 : 1517-1526, 1998
PubMed
12) Bloksma N, Hofhuis FMA, Willers JMN : Muramyl dipeptide analogues as potentiators of the antitumor action of endotoxine. Cancer Immunol Immunother 19 : 205-210. 1985
 
13) Tsujimoto M, Kotani S, Shibata T, et al. : Regressive action with induction of hemorrhagic necrosis of mixtures of acylated muramylpeptides and synthetic, low toxic lipid A analogs on Meth A fibrosarcoma. Adv Biosci 68 : 151-165, 1988
 
13) Vinogradov E V, Lindner B, Kocharova N A, et al. : The core structure of the lipopolysaccharide from the causative agent of plague, Yersinia pestis. Carbohydr Res 337 : 775-777, 2002
PubMed
14) Takada H and Galanos C : Enhancement of endotoxin Iethality and generation of anaphylactoid reactions by lipopolysaccharides in muramyl-dipeptide-treated mice. Infect Immun 55 : 409-413, 1987
PubMed
14) Hitchen P G, Prior J L, Oyston P C, et al. : Structural characterization of lipo-oligosaccharide (LOS) from Ye rsin ia pestis : regulation of LOS structure by the phoPQ system. Mol Microbiol 44 : 1637-1650, 2002
 
15) Kawahara K, Brade H, Rietschel E T, et al. : Studies on the chemical structure of the corelipid A region of the lipopolysaccharide of Acinetobacter calcoaceticzas NCTC 10305. Eur J Biochem 163 : 489-495, 1987
PubMed
15) Takada H, Hirai H, Fujiwara T, et al. : Bacte ro ides lipopolysaccharides (LPS) induce anaphylactoid and lethal reactions in LPS-responsive and-nonresponsive mice primed with muramyl dipeptide. J Infect Dis 162 : 428-434, 1990
 
16) Shibazaki M, Kawabata Y, Yokochi T, et al. : Complement-dependent accumulation and degradation of platelets in the lung and liver induced by injection of lipopolysaccharides. Infect Immun 67 : 5186-5191, 1999
PubMed
16) Isshiki Y, Kawahara K, and Zahringer U : Isolation and characterization of disodium (4-amino-4-deoxy-β-L-arabinopyranosyl) - (1→8) - (D-9 lycero-α-D-talo-oct-2-ulopyranosylonate) (2→4) - (methyl 3-deoxy-Dmannooct-2-ulopyranosid) onate from the lipopolysaccharide of Burkholderia cepacia. Carbohydr Res 313 : 21-27, 1998
 
17) Kawabata Y, Yang S, Yokochi T, et al. : Complement system is involved in anaphylactoid reaction induced by lipopolysaccharides in muramyldipeptide-treated mice. Shock 14 : 572-577, 2000
 
17) Rick P D, Fung L W-M, Ho C, et al. : Lipid A mutants of Salmonella typhimurium. Purification and characterization of a lipid A precursor produced by a mutant in 3-deoxy-D-mannooctulosonate-8-phosphate synthetase. J Biol Chem 252 : 4904-4912, 1977
 
18) Nishijima M, Bulawa C E, and Raetz C R : Two interacting mutations causing temperature-sensitive phosphatidylglycerol synthesis in Escherichia co li membranes. J Bacteriol 145 : 113-121, 1981
 
18) Zhao L, Ohtaki Y, Yamaguchi K, et al. : LPS-induced platelet response and rapid shock in mice : contribution of O-antigen region of LPS and involvement of the lectin pathway of the complement system. Blood 100 : 3233-3239, 2002
 
19) Parant M, Parant F, Vinit M-A, et al. : Priming effect of muramyl peptides for induction by lipopolysaccharide of tumor necrosis factor production in mice. J Leukoc Biol 47 : 164-169, 1990
PubMed
19) Shiba T, Kusumoto S, Inage M, et al. : Recent developments in the organic synthesis of lipid Ain relation to biologic activities. Rev Infect Dis 6 : 478-482, 1984
 
20) Takada H, Kawabata Y, Tamura M, et al. : Cytokine induction by extracellular products of oral viridans group streptococci. Infect Immun 61 : 5252-5260, 1993
PubMed
20) Raetz C R : Biochemistry of endotoxins. Annu Rev Biochem 59 : 129-170, 1990
PubMed
21) Takada H, Kawabata Y, Arakaki R, et al. : Molecular and structural requirements of a lipoteichoic acid from Enterococcus hirae ATCC 9790 for cytokine-inducing, antitumor, and antigenic activities. Infect Immun 63 : 57-65, 1995
PubMed
21) Carty S M, Sreekumar K R, and Raetz C R : Effect of cold shock on lipid A biosynthesis in Escherichia coli. J Biol Chem 274 : 9677-9685, 1999
PubMed
22) Monodane T, Kawabata Y, Yang S, et al. : Induction of tumour necrosis factor-α and interleukin-6 in mice in vivo and in murine peritoneal macrophages and human whole blood cells in vitro by Micrococcus luteus teichuronic acids. J Med Microbiol 50 : 4-12, 2001
 
22) Vorachek-Warren M K, Carty S M, Lin S, et al. : An Escherichia coli mutant lacking the cold shock-induced palmitoleoyltransferase of lipid A biosynthesis. J Biol Chem 277 : 14186-14193, 2002
PubMed
23) Tsuchida K, Takemoto Y, Yamagami S, et al. : Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and Limulus amebocyte lysate methods. Nephron 75 : 438-443, 1997
PubMed
23) Jones B D, Nichols W A, Gibson B W, et al. : Study of the role of the htrB gene in Salmonella typhimurium virulence. Infect Immun 65 : 4778-4783, 1997
PubMed
24) Wolfert MA, Murray TF, Boons G-J, et al. : The origin of the synergistic effect of muramyl dipeptide with endotoxin and peptidoglycan. J Biol Chem 277 : 39179-39186, 2002
PubMed
24) Khan S A, Everest P, Servos S, et al. : A lethal role for lipid A in Salmonella infections. Mol Microbiol 29 : 571-579, 1998
PubMed
25) Nagao S, Akagawa KS, Yamada K, et al. : Lack of response of murine peritoneal macrophages to in vitro activation by muramyl dipeptide (MDP). I. Macrophage activation by MDP is species dependent. Microbiol Immunol 34 : 323-335, 1990
PubMed
26) Katschinski T, Galanos C, Coumbos A, et al. : Gamma interferon mediates Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice. Infect Immun 60 : 1994-2001, 1992
PubMed
27) Kamijo R, Le J, Shapiro D, et al. : Mice that lack the interferon-γ receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J Exp Med 178 : 1435-1440, 1993
 
28) Freudenberg MA. Kopf M. Galanos C : Lipopolysaccharide-sensitivity of interferon-γ receptor deficient mice. J Endotoxin Res 3 : 291-295, 1996
 
29) Beigneux A, Huang J, Le Contel C, et al. : Differential role of interferon-γ in the potentiating effect of muramyl peptides for enhanced responses to lipopolysaccharide in mice : effect of cyclosporin A. J Interferon Cytokine Res 14 : 359-365, 1995
 
30) Inohara N, Ogura Y, Fontalba A, et al. : Host recognition of bacterial muramyl dipeptide mediated through NOD 2 : implications for Crohn's disease. J Biol Chem 278 : 5509-5512, 2003
 
31) Girardin SE, Boneca IG, Viala J, et al. : Nod 2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) Chem 278 : 8869-8872, 2003 detection. J Biol Chem 278 : 8869-8872, 2003
 
P.79 掲載の参考文献
1) Takada H, Kotani S : Immunopharmacological activities of synthetic muramyl-peptides. In "Immunology of the Bacterial Cell Envelope", eds Stewart-Tull DES, Davies M, John Wiley & Sons, Chichester, 1985, p 119-152
 
P.92 掲載の参考文献
1) Hancock R E W, Diamond G : The role of cationic antimicrobial peptides in innate host defences. Trends Micobiol 8 : 402-410, 2000
 
2) Zanetti M, Gennaro R, Romeo D : Cathelicidins : a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 374 : 1-5, 1995
 
3) Gennaro R, Zanetti M : Structural features and biological activities of the cathelicidinderived antimicrobial peptides. Biopolymers 55 : 31-49, 2000
PubMed
4) Travis S M, Anderson N N, Forsyth W R, et al. : Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun 68 : 2748-2755, 2000
PubMed
5) Ramanathan B, Davis E G, Ross C R, et al. : Cathelicidins : microbicidal activity, mechanisms of action, and roles in innate immunity. Microbes Infect 4 : 361-372, 2002
PubMed
6) Gudmundsson G H, Agerberth B : Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. J Immunol Methods 232 : 45-54, 1999
PubMed
7) Hirata M, Shimomura Y, Yoshida M, et al. : Characterization of a rabbit cationic protein (CAP 18) with lipopolysaccharide-inhibitory activity. Infect Immun 62 : 1421-1426, 1994
PubMed
8) Larrick J W, Hirata M, Balint R F, et al. : Human CAP 18 : a novel antimicrobial lipopolysaccharide-binding Protein. Infect Immun 63 : 1291-1297, 1995
 
9) Kirikae T, Hirata M, Yamasu H, et al. : Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP 18) -derived peptide against murine endotoxemia. Infect Immun 66 : 1861-1868, 1998
PubMed
10) Sawa T, Kurahashi K, Ohara M, et al. : Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP 18 fragment against Pseudomonas aeruginosa in amouse model. Antimicrob Agents Chemother 42 : 3269-3275, 1998
 
11) Nagaoka I, Hirota S, Niyonsaba F, et al. : Cathelicidin family of antibacterial peptides CAP 18 and CAP 11 inhibit the expression of TNF-α by blocking the binding of LPS to CD 14+ cells. J Immunol 167 : 3329-3338, 2001
 
12) Morrison D C, Danner R L, Dinarello C A, et al. : Bacterial endotoxins and pathogenesis of Gram-negative infections : current status and future direction. J Endotoxin Res 1 : 71-83, 1994
 
13) Fenton M J, Golenbock D T : LPS-binding proteins and receptors. J Leukoc Biol 64 : 25-32, 1998
PubMed
14) Aderem A, Ulevitch R J : Toll-like receptors in the induction of the innate immune response. Nature 406 : 782-787, 2000
PubMed
15) Wright S D, Ramos R A, Tobias P S, et al. : CD 14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 : 1431-1433, 1990
 
16) Nagaoka I, Hirota S, Niyonsaba F, et al. : Augmentation of the lipopolysaccharideneutralizing activities of human cathelicidin CAP 18/LL-37-derived antibacterial peptides by replacement with hydrophobic and cationic amino acid residues. Clin Diagn Lab Immunol 9 : 972-982, 2003
 
17) Seydel U, Schromm A B, Blunck R, et al. : Chemical structure, molecular conformation, and bioactivity of endotoxins. Chem Immunol 74 : 5-24, 2000
PubMed
18) Adachi Y, Satokawa C, Saeki M, et al. : Inhibition by a CD 14 monoclonal antibody of lipopolysaccharide binding to murine macrophages. J Endotoxin Res 5 : 139-146, 1999
 
19) Adachi Y, Shibahara M, Murakami T, et al. : Epltope characterization of neutralizing anti-body for murine CD 14. J Endotoxin Res 8 : 180, 2002
 
20) Galanos C, Freudenberg M A, Reutter W : Galactosamine-induced sensitization of the lethal effects of endotoxin. Proc Natl Acad Sci USA 76 : 5939-5943, 1979
PubMed
21) Lehrer R I, Lichtenstein A K, Ganz T : Defensins : antimicrobial and cytotoxic peptides of mammalian cells. Ann Rev Immunol 11 : 105-128, 1993
 
22) Nagaoka I, Hirota S, Yomogida S, et al. : Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm Res 49 : 73-79, 2000
PubMed
23) Scott M G, Vreugdenhil A C E, Buurman W A, et al. : Cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J Immunol 164 : 549-553, 2000
 
24) Larrick J W, Hirata M, Shimomura Y, et al. : Antimicrobial activity of rabbit CAP 18-derived peptides. Antimicrob Agents Chemother 37 : 2534-2539, 1993
 
25) Larrick J W, Hirata M, Zhong J, et al. : Antimicrobial activity of human CAP 18 peptides. Immunotechnology 1 : 65-72, 1995
 
P.101 掲載の参考文献
1) Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al. : Impact of infectious burden on progression of carotid atherosclerosis. Stroke 33 : 2581-2586, 2002
PubMed
2) Wannamethee SG, Shaper AG : Alcohol, coronary heart disease and stroke : an examination of the J-shaped curve. Neuroepidemiology 17 : 288-295, 1998
 
3) Langer RD, Criqui MH, Reed DM : Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation 85 : 910-915, 1992
PubMed
4) Krobot K, Hense HW, Cremer P, et al. : Determinants of plasma fibrinogen : relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg survey 1989-1990. Arterioscler Thromb 12 : 780-788, 1992
PubMed
5) Laug WE : Ethyl alcohol enhances plasminogen activator secretion by endothelial cells. JAMA 12, 250 : 772-776, 1983
 
6) Meade TW, Vickers MV, Thompson SG, et al. : Epidemiological characteristics of platelet aggregability. Br Med J (Clin Res Ed) 9, 290 : 428-432, 1985
 
7) Hillbom M : Alcohol consumption and stroke : benefits and risks. Alcohol Clin Exp Res 22 (7 Suppl) : 352 S-358 S, 1998
 
8) MacMahon S : Alcohol consumption and hypertension. Hypertension 9 : 111-121, 1987
PubMed
9) Moncada S, Palmer RM, Higgs EA : Nitric oxide : physiology, pathophysiology, and pharmacology. Pharmacol Rev 43 : 109-142, 1991
PubMed
10) Mitchell JA, Larkin S, Williams TJ : Cyclooxygenase-2 : regulation and relevance in inflammation. Biochem Pharmacol 50 : 1535-1542, 1995
PubMed
11) Maxwell AJ, Tsao PS, Cooke Jp : Modulation of the nitric oxide synthase pathway in atherosclerosis. Exp Physiol 83 : 573-584, 1998
PubMed
12) Gewaltig MT, Kojda G : Vasoprotection by nitric oxide : mechanisms and therapeutic potential. Cardiovasc Res 55 : 250-260, 2002
PubMed
13) Buttery LD, Springall DR, Chester AH, et al. : Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 75 : 77-85, 1996
PubMed
14) Baker CS, Hall RJ, Evans TJ, et al. : Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. Arterioscler Thromb Vasc Biol 19 : 646-655, 1999
 
15) Behr-Roussel D, Rupin A, Simonet S, et al. : Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits. Circulation 102 : 1033-1038, 2000
 
16) Detmers PA, Hernandez M, Mudgett J, et al. : Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J Immunol 165 : 3430-3435, 2000
PubMed
17) Ischiropoulos H, Zhu L, Beckman JS : Peroxynitrite formation from macrophagederived nitric oxide. Arch Biochem Biophys 298 : 446-451, 1992
PubMed
18) Olesen M, Kwong E, Meztli A, et a1. : No Effect of Cyclooxygenase Inhibition on Plaque Size in Atherosclerosis-prone Mice. Scand Cardiovasc J 36 : 362-367, 2002
 
19) Chenevard R, Hurlimann D, Bechir M, et al. : Selective COX-2 inhibition improves endothelial function in coronary artery disease. Circulation 28 107 : 405-409, 2003
 
20) Burleigh ME, Babaev VR, Oates JA, et al. : Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptordeficient mice. Circulation. 105 1816-1823, 2002
PubMed
21) Greenberg SS, Xie J, Wang Y, et al. : Ethanol suppresses LPS-induced mRNA for nitric oxide synthase II in alveolar macrophages in vivo and in vitro. Alcohol 11 : 539-547, 1994
PubMed
22) Kimura H, Miura S, Higuchi H, et al. : Effect of chronic ethanol feeding on nitric oxide synthesis by rat Kupffer cells. Alcoholism Clin Exp Res 20 (1 Suppl) : 69 A-72 A, 1996
 
23) Durante W, Cheng K, Sunahara RK, et al. : Ethanol potentiates interleukin-1 β-stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells. Biochemical J 308 : 231-236, 1995
 
24) Naassila M, Roux F, Beauge F, et al. : Ethanol potentiates lipopolysaccharide- or interleukin-1 β-induced nitric oxide generation in RBE 4 cells. Eur J Pharmacol 313 : 273-237, 1996
 
25) Chan MM, Mattiacci JA, Hwang HS, et al. : Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. Biochem Pharmacol 60 : 1539-1548, 2000
PubMed
26) Ohmori Y, Hamilton TA : Requirement for STAT 1 in LPS-induced gene expression in macrophages. J Leukoc Biol 69 : 598-604, 2001
 
27) Pouliot M, Gilbert C, Borgeat P, et al. : Expression and activity of prostaglandin endoperoxide synthase-2 in agonist-activated human neutrophils. FASEB J 12 : 1109-1123, 1998
PubMed
28) Knapp DJ, Crews FT : Induction of cyclooxygenase-2 in brain during acute and chronic ethanol treatment and ethanol withdrawal. Alcohol Clin Exp Res 23 : 633-643, 1999
PubMed
29) Nanji AA, Miao L, Thomas P, et al. : Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat. Gastroenterology 112 : 943-951, 1997
PubMed
30) Bermudez LE : Effect of ethanol on the interaction between the macrophage and Mycobacterium avium. Alcohol 11 : 69-73, 1994
PubMed
31) Holt S, Stewart IC, Dixon JM, et al. : Alcohol and the emergency service patient. Br Med J 281 : 638-640, 1980
PubMed
32) Wang JY, Wang JY, Wang JY, et al. : Ethanol modulates induction of nitric oxide synthase in glial cells by endotoxin. Life Sci 63 : 1571-1583, 1998
PubMed
P.110 掲載の参考文献
1) 平沢博之 : SIRSの概念の提唱とその背景. "SIRS (全身性炎症反応症候群)"別冊・医学のあゆみ, 小川道雄編. 医歯薬出版, 1997, p3-7
 
2) Sakaguchi S, Kanda N, Hsu CC, et al. : Lipid peroxide formation and membrane damage in endotoxin-poisoned mice. Microbiol Immunol 25 : 229-244, 1981
PubMed
3) Sakaguchi O, Kanda N, Sakaguchi S, et al. : Effect of α-tocopherol on endotoxicosis. Microbiol Immunol 25 : 787-799, 1981
 
4) Sakaguchi S, Furusawa S, Yokota K, et al. : The enhancing effect of tumour necrosis factor-α on oxidative stress in endotxemia. Pharmacol Toxicol 79 : 259-265, 1996
 
5) Sakaguchi S, Ibata H, Yokota, K : Effect of calcium ion on lipid peroxide formtion in endotoemic mice. Microbiol Immunol 33 : 99-110, 1989
 
6) Sakaguchi S, Tsutsumi E, Yokota K : Decline in plasma membrane Ca2+-ATPase activity and increase in cytosolic-free Ca2+ concentration of endotoxin-injected mice livers. Biol Pharm Bull 16 : 808-810, 1993
PubMed
7) Gaetke LM, McClain CJ, Talwalkar RT, et al. : Effects of endotoxin on zinc metabolism in human volunteers. Am J physiol 272 : E952-E956, 1997.
PubMed
8) Nath R, Kumar D Li T, Singal PK : Metallothioneins, oxidative stress and the cardiovascular system. Toxicol 155 : 17-26, 2000
 
9) Bremmer I, Beattie JH : Metallothionein and the trace minerals. Annu Rev Nutr 10 : 63-83, 1990
 
10) Cai L, Klein JB, Kang YJ, et al. : Metallothionein inhibits peroxynitrite-induced DNA and lipoprotein damage. J Biol Chem 275 : 38957-38960, 2000
PubMed
11) 鈴木和夫 : メタロチオネインの構造と機能. 特集 "必須微量元素の臨床". 日本臨床 54 : 33-39, 1996
 
12) 佐藤雅彦 : 酸化ストレスに対するメタロチオネインの生理学的意義 "酸化ストレス" 別冊・医学のあゆみ, 吉川敏一編. 医歯薬出版, 2001, p315-318
 
13) Sakaguchi S, Iizuka Y, Furusawa S, et al. : Role of Zn2+ in oxidative stress caused by endotoxin challenge. Eur J Pharmacol 451 : 309-316, 2002
PubMed
14) Barceloux DG : Selenium. J Clin Toxicol 37 : 145-172, 1999
 
15) Sakaguchi S, Iizuka Y, Furusawa S, et al. : Roles of selenium in endotoxin-induced lipid peroxidation in the rats liver and in nitric oxide production in J 774 A. 1 cells. Toxicol Lett 118 : 69-77, 2000
 
16) Sakurai H, Satoh H, Hatanaka A, et al. : Unusual generation of hydroxyl radicals in hepatic copper metallothionein of LEC (Long-Evans Cinnamon) rats in the presence of hydrogen peroxide. Biochem Biophys Res Commun 199 : 313-318, 1994
PubMed
17) Unoshima M, Nishizono A, Takita-Sonoda Y, et al. : Effects of zinc acetate on suplenocytes of endotoxemic mice : enhanced immune response, reduced apoptosis, and increased expression of heat shock protein 70. J Lab Clin Med 137 : 28-37, 2001
PubMed
18) Sakaguchi S, Yokota K : Role of Ca2+ on endotoxin-sensitivity by galactosamine challenge : lipid peroxide formation and hepatotoxicity in zymosan-primed mice. Pharmacol Toxicol 77 : 81-86, 1995
PubMed
19) Moncada S, Palmer RMJ, Higgs EA : Nitric oxide : physiology, pathophysiology and pharmacology. Pharmacol Rev 43 : 109-142, 1991
 
20) Titheradge MA : Nitric oxide in septic shock. Biochim Biophys Acta 1411 : 437-455, 1999
PubMed
21) Sakaguci S, Furusawa S, Yokota K, et al. : Effect of nitric oxide synthase inhibitors on lipid peroxide formation in liver caused by endotoxin challenge. Pharmacol Toxicol 86 : 162-168, 2000
 
22) Sakaguchi S, Furusawa S, Takayanagi M, et al. : Effects of NG-nitro-L-arginine methyl ester on endotoxin-induced leakage of lactate dehydrogenase and cytotoxicity in J 774 A. 1 cells. FEMS Microbiol Lett 196 : 39-43, 2001
 
23) MacMicking JD, Nathan C, Hom C, et al. : Altered reponses to bacterial infection and endotoxin shock in mice lacking inducible nitric oxide synthase. Cell 81 : 641-650, 1995
 
24) Asahi M, Fujii J, Suzuki K, et al. : Inactivation of glutathione peroxide by nitric oxide. J Biol Chem 270 : 21035-21039, 1995
PubMed
25) 児玉浩子 : 免疫機能維持に関わる必須微量元素の役割. 特集 "必須微量元素の臨床". 日本臨床 54 : 46-51, 1996
 
P.118 掲載の参考文献
1) Shwartzman G : Phenomenon of local tissue reactivity and its immunological, pathological and clinical significance. New York, Paul B Hober, 1937 .
 
2) Wysocka M, Kubin M, Vieira LQ, et al. : Interleukin-12 is required for interferongamma production and lethality in lipopolysacchar-ide- induced shock in mice. Eur J Immunol 25 : 672-676, 1995
 
3) Ozmen L, Pericin M, Hakimi J, et al. : Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction. J Exp Med 180 : 907-915, 1994
PubMed
4) Ogasawara K, Takeda K, Hashimoto W, et al. : Involvement of NK 1+ T cells and their IFN-gamma production in the generalized Shwartzman reaction. J Immunol 160 : 3522-3527, 1998
PubMed
5) Ono S, Tamakuma S, Mochizuki H, et al. : Clinico-experimental analysis of backgrounds of the severe surgical infections. Nippon Geka Gakkai Zasshi 92 : 1300-1303, 1991
PubMed
6) Seki S, Habu Y, Kawamura T, et al. : The liver as a crucial organ in the first line of host defense : the roles of Kupffer cells, natural killer (NK) cells and NK 1.1 Ag+ T cells in T helper 1 immune responses. Immunol Rev 174 : 35-46, 2000
 
7) Takeda K, Hayakawa Y, Atsuta M, et al. : Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12. Int Immunol 12 : 909-914, 2000
 
8) Inui T, Nakagawa R, Ohkura S, et al. : Ageassociated augmentation of the synthetic ligand-mediated function of mouse NK 1.1 ag (+) T cells : their cytokine production and hepatotoxicity in vivo and in vitro. J Immunol 169 : 6127-6132, 2002
PubMed
9) Takayama E, Seki S, Ohkawa T, et al. : Mouse CD 8+ CD 122+ T cells with intermediate TCR increasing with age provide a source of early IFN-gamma production. J Immunol 164 : 5652-5658, 2000
 
10) Ohkawa T, Seki S, Dobashi H, et al. : Systematic characterization of human CD 8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD 8+ T cells. Immunology 103 : 281-290, 2001
 
P.125 掲載の参考文献
1) Alexander C, Rietschel ETh : Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 7 : 167-202, 2001
 
2) Ulmer AJ, Rietschel Eth, Zahringer U, et al. : Lipopolysaccharide : structure, bioactivity, receptors, and signal transduction. Trends Glycosci Glycotechnol 14 : 53-68, 2002
 
3) Akira S, Takeda K, Kaisho T : Toll-like receptors : critical proteins linking innate and acquired immunity. Nat Immunol 2 : 675-680, 2001
PubMed
4) Vasselon T, Detmers PA : Toll receptors : a central element in innate immune responses. Infect Immun 70 : 1033-1041, 2002
PubMed
5) Antal-Szalmas P : Evaluation of CD 14 in host defense. Eur J CIin Invest 30 : 167-179, 2000
 
6) Yoshimura A, Lien E, Ingalls RR, et al. : Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 163 : 1-5, 1999
PubMed
7) Kielian TL, Blecha F : CD 14 and other recognition molecules for lipopolysaccharide : a review. Immunopharmacology 29 : 187-205, 1995
 
8) Pugin J, Schttrer-Maly C-C, Leturcq D, et al. : Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 90 : 2744-2748, 1993
 
9) Backhed F, Meijer L, Normark S, et al. : TLR 4-dependent recognition of lipopolysaccharide by epithelial cells requires sCD 14. Cell Microbiol 4 : 493-501, 2002
 
10) Putnins EE, Sanaie A-R, Wu Q, et al. : Induction of keratinocyte growth factor l expression by lipopolysaccharide is regulated by CD-14 and Toll-like receptors 2 and 4. Infect Immun 70 : 6541-6548, 2002
 
11) Jersmann HPA, Hii CST, Hodge GL, et al. : Synthesis and surface expression of CD 14 by human endothelial cells. Infect Immun 69 : 479-485, 2001
 
12) Tamai R, Sakuta T, Matsushita K, et al. : Human gingival CD 14+fibroblasts primed with gamma interferon increase production of interleukin-8 in response to lipopolysaccharide through up-regulation of membrane CD 14 and MyD 88 mRNA expression. Infect Immun 70 : 1272-1278, 2002
 
13) Hedlund M, Frendeus B, Wachtler C, et al. : Type 1 fimbriae deliver an LPS-and TLR 4-dependent activation signal to CD 14-negative cells. Mol Microbiol 39 : 542-552, 2001
 
14) Funfstuck R, Franke S, Hellberg M, et al. : Secretion of cytokines by uroepithelial cells stimulated by Escherichia coli and Citrobacter spp. Int J Antimicrob Agents 17 : 253-258, 2001
PubMed
15) Backhed F, s6derhall M, Ekman P, et al. : Induction of innate immune responses by Escherichia coli and purified lipopolysaccharide correlate with organ-and cell-specific expression of Toll-like receptors within the human urinary tract. Cell Microbiol 3 : 153-158, 2001
 
16) Grimm MC, Pavli P, van de Pol E, et al. : Evidence for a CD 14+ population of monocytes in inflammatory bowel disease mucosa-implications for pathogenesis. Clin Exp Immunol 100 : 291-297, 1995
 
17) Parsons PE, Gillrspie MM, Moore EE, et al. : Neutrophil response to endotoxin in the adult respiratory distress syndrome : role of CD 14. Am J Respir Cell Mol Biol 13 : 152-160, 1995
 
18) Nockher WA, Scherberich JE : Expression and release of the monocyte lipopolysaccharide receptor antigen CD 14 are suppressed by glucocorticoid in vivo and in vitro. J Immunol 158 : 1345-1352, 1997
 
19) Baldini M, Lohman IC, Halonen M, et al. : A polymorphism in the 5'flankling region of the CD 14 gene is associated with circulating soluble CD 141evels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 20 : 976-983, 1999
 
20) Karhukorpi J, Yan Y, Niemela S, et al. : Effect of CD 14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD 14. Clin Exp Immunol 128 : 326-332, 2002
 
21) Uehling DT, Johnson DB, HoPlins WJ : The urinary tract response to entry of pathogens. World J Urol 17 : 351-358, 1999
 
P.134 掲載の参考文献
1) Akashi S, Shimazu R, Ogata H, et al. : Cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol 164 : 3471-3475, 2000
PubMed
2) Wright SD, Ramos RA, Tobias PS, et al. : CD 14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 : 1431-1433, 1990
 
3) Stelter F : Structure/function relationship of CD 14. Chem Immunol 74 : 25-41, 2000
 
4) Adachi Y, Satokawa C, Saeki M, et al. : Inhibition by a CD 14 monoclonal antibody of lipopolysaccharide binding to murine macrophages. J Endotoxin Res 5 : 139-146, 1999
 
5) Le Roy D, Di Padova F, Adachi Y, et al. : Critical role of lipopolysaccharide-binding protein and CD 14 in immune responses against gram-negative bacteria. J Immunol 167 : 2759-2765, 2001
 
6) Yamamoto S, Matsuura K, Ishida T, et al. : Characterization and use of mAb against mouse CD 14. In "Leucocyte Typing V", eds Schlossman SF, Boumsell L, Gilks W, et al, Oxford University Press, Oxford, 1995, p 788-790
 
7) Ferrero E, Hsieh CL, Francke U, et al. : CD 14 is a member of the family of leucine-rich proteins and is encoded by a gene syntenic with multiple receptor genes. J Immunol 145 : 331-336, 1990
 
8) Nagaoka I, Hirota S, Niyonsaba F, et al. : Cathelicidin family of antibacterial peptides CAP 18 and CAP 11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD 14 (+) cells. J Immunol 167 : 3329-3338, 2001
 
9) Nagaoka I, Hirota S, Niyonsaba F, et al. : Augmentation of the lipopolysaccharideneutralizing activities of human cathelicidin CAP 18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues. Clin Diagn Lab Immunol 9 : 972-982, 2002
PubMed
10) Juan TS, Kelley MJ, Johnson DA, et al. : Soluble CD 14 truncated at amino acid 152 binds lipopolysaccharide (LPS) and enables cellular response to LPS. J Biol Chem 270 : 1382-1387, 1995
 
11) da Silva Correia J, Soldau K, Christen U, et al. : Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex transfer from CD 14 to TLR 4 and MD-2. J Biol Chem 276 : 21129-21135, 2001
 
12) Jiang Q, Akashi S, Miyake K, et al. : Lipopolysaccharide induces physical proximity between CD 14 and toll-like receptor 4 (TLR 4) prior to nuclear translocation of NFkappa B. J Immunol 165 : 3541-3544, 2000
 
13) Viriyakosol S, Kirkland TN : Aregion of human CD 14 required for lipopolysaccharide binding. J Biol Chem 270 : 361-368, 1995
 
14) Dziarski R, Tapping RI, Tobias PS : Binding of bacterial peptidoglycan to CD 14. J Biol Chem 273 : 8680-8690, 1998
 
15) Haziot A, Chen S, Ferrero E, et al. : The monocyte differentiation antigen, CD 14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 141 : 547-552, 1988
 
16) Frey EA, Miller DS, Jahr TG, et al. : Soluble CD 14 participates in the response of cells to lipopolysaccharide. J Exp Med 176 : 1665-1671, 1992
 
17) Shimazu R, Akashi S, Ogata H, et al. : MD-2, amolecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 189 : 1777-1782, 1999
 
P.141 掲載の参考文献
1) Shimazu R, Akashi S, Ogata H, et al. : MD-2, amolecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 189 : 1777-1782, 1999
 
2) Yang RB, Mark MR, Gray A, et al. : Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395 : 284-288, 1998
PubMed
3) Kirschning CJ, Wesche H, Merrill Ayres T, et al. : Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med 188 : 2091-2097, 1998
PubMed
4) Takeuchi O, Hoshino K, Kawai T, et al. : Differential roles of TLR 2 and TLR 4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11 : 443-451, 1999
PubMed
5) Heine H, Kirschning CJ, Lien E, et al. : Cells that carry a null allele for Toll-like receptor 2 are capable of responding to endotoxin. J Immunol 162 : 6971-6975, 1999
 
6) Hirschfeld M, Ma Y, Weis JH, et al. : Repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J Immunol 165 : 618-622, 2000
PubMed
7) Tapping RI, Akashi S, Miyake K, et al. : Toll-like receptor 4, but not Toll-like receptor 2, is a signaling receptor for Escherichia and Sa lmonella lipopolysaccharides. J Immunol 165 : 5780-5787, 2000
PubMed
8) Means TK, Golenbock DT, and Fenton MJ : The biology of Toll-like receptors. Cytokine Growth Factor Rev 11 : 219-232, 2000
PubMed
9) Ulmer AJ, Dziarski R, El-Samalouti V, et al. : CD 14, an innate immune receptor for various bacterial cell wall components. In "Endotoxin in Health and Disease". eds Brade H, Opal S M, Vogel S N, and Morrison D C, Marcel Dekker Inc, NY, 1999, p 463-472
 
10) Muroi M, Ohnishi T, and Tanamoto K : Regions of the mouse CD 14 molecule required for Toll-like receptor 2- and 4-mediated activation of NF-κB. J Biol Chem 277 : 42372-42379, 2002
 
11) Juan TS, Kelley MJ, Johnson DA, et al. : Soluble CD 14 truncated at amino acid 152 binds lipopolysaccharide (LPS) and enables cellular response to LPS. J Biol Chem 270 : 1382-1387, 1995
 
12) Juan TS, Hailman E, Kelley MJ, et al. : Identification of a lipopolysaccharide binding domain in CD 14 between amino acids 57 and 64. JBiol Chem 270 : 5219-5224, 1995
 
13) Juan TS, Hailman E, Kelley MJ, et al. : Identification of a domain in soluble CD 14 essential for lipopolysaccharide (LPS) signaling but not LPS binding. J Biol Chem 270 : 17237-17242, 1995
PubMed
14) Shapiro RA, Cunningham MD, Ratcliffe K, et al. : Identification of CD 14 residues involved in specific lipopolysaccharide recognition. Infect Immun 65 : 293-297, 1997
 
15) Viriyakosol S, Mathison JC, Tobias PS, et al. : Structure-function analysis of CD 14 as a soluble receptor for lipopolysaccharide. J Biol Chem 275 : 3144-3149, 2000
 
16) Cunningham MD, Shapiro RA, Seachord C, et al. : CD 14 employs hydrophilic regions to "capture" lipopolysaccharides. J Immunol 164 : 3255-3263, 2000
 
17) Viriyakosol S and Kirkland TN : The N-terminal half of membrane CD 14 is a functional cellular lipopolysaccharide receptor. Infect Immun 64 : 653-656, 1996
 
18) Viriyakosol S and Kirkland TN : Aregion of human CD 14 required for lipopolysaccharide binding. J Biol Chem 270 : 361-368, 1995
 
19) Stelter F, Bernheiden M, Menzel R, et al. : Mutation of amino acids 39-440f human CD 14 abrogates binding of lipopolysaccharide and Escherichia coli. Eur J Biochem 243 : 100-109, 1997
 
20) Jiang Q, Akashi S, Miyake K, et al. : Lipopolysaccharide induces physical proximity between CD 14 and Toll-like receptor 4 (TLR 4) prior to nuclear translocation of NF-κB. J Immunol 165 : 3541-3544, 2000
 
21) Tanamoto K and Azumi S : Salmonella-type heptaacylated lipid A is inactive and acts as an antagonist of lipopolysaccharide action on human line cells. J Immunol 164 : 3149-3156, 2000
 
22) Muroi M, Ohnishi T, and Tanamoto K : MD-2, a novel accessory molecule, is involved in species-specific actions of Salmonella Iipid A. Infect Immun 70 : 3546-3550, 2002
 
23) Poltorak A, Ricciardi-Castagnoli P, CitterioS, et al. : Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation. Proc Natl Acad Sci USA 97 : 2163-2167, 2000
PubMed
24) Lien E, Means TK, Heine H, et al. : Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 105 : 497-504, 2000
PubMed
25) Akashi S, Nagai Y, Ogata H, et al. : Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int Immunol 13 : 1595-1599, 2001
PubMed
P.156 掲載の参考文献
1) Chernow B, Rath BL : Pharmacologic manipululation of the peripherol vasculature in shock : clinical and experimental approaches. Circ shock 18 : 141-155, 1986
 
2) Dunser MW, Mayr AJ, Ulmer H, et al. : The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and post cardiotomy shock : aretrospective analysis. Cardiovasc Anesth 93 : 7-13, 2001
 
3) Suga H, Nakagawa T, Miyoshi N, et al. : Comparison of nitric oxide (NO) production in the tissue following hemorrhagic invasion and endotoxin adminiatration in rats in relation to pathogenesis of traumatic DIC. J Tokyo Women's Med Univ 70 : 80-91, 2000
 
4) Thiemarmann C : Nitric oxide and septic shock. Gen Pharmacol 29 : 159-166, 1997
 
5) 芳賀克夫, 小川道雄 : Hyperdynamic stateとchenical mediator. 外科治療 76 : 153-159, 1997
 
6) Moncada S, Higge A : The L-arginine-nitric oxide pathway. New England J Med 329 : 2002-2012, 1993
 
7) Moncada S, Palmer RMJ, Higgs EA : Nitric oxide. physiology, pathophysiology and pharmacolog. Pharmacol Rev 43 : 109-142, 1991
 
8) Vincent JL, Preiser JC, Zhang H : Blocking the effects of nitric oxide in septic shock. In "Role of Nitric Oxide in Sepsis and ARDS", eds Fink MP, Payen D, Springer, Berlin, 1995, p253-273
 
9) Szabo C, Southan GI, Thiemermann C : Beneficial effects and impruved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitior of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91 : 12472-12476, 1994
 
10) Higgins TL, Chernow B : Pharmacotherapy of circulatory shock. Dis Mon 33 : 309-361, 1987
PubMed
11) Groeneveld ABJ, Girbes ARJ, Thijs LG : Treating septic shock with norepinephrine. Crit Care Med 27 : 2022-2023, 1999
 
12) Chernow B, Roth BL : Pharmachologic manipulation of the peripheral vasculature in shock ; clinical and experimental approaches. Circ Shock 18 : 141-155, 1986
 
13) Robertson FM, Offner PJ, Ciere DP, et al. : Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 129 : 149-156, 1994
 
14) Minnard EA, Shou J, Naama H, et al. : Inhibition of nitric oxide synthasis is detrimental during endotoxemia. Arch Surg 129 : 142-148, 1994
PubMed
15) Aranow JS, Zhuang J, Wang H, et al. : A selective inhibition of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis : comparison with two nonselective strategies. Shock 5 : 116-121, 1996
 
16) Mac Micking JD, Nathan C, Hom G, et al. : Altered response to bacterial infection and endotoxin shock in mice lacking inducible nitric oxide synthase. Cell 81 : 641-650, 1995
PubMed
17) Wei XQ, Charles IG, Smith A, et al. : Altered responses in mice lacking inducible nitric oxide aynthase. Nature 375 : 408-411
 
18) Broccard A, Hurni JMs Eckert P, et al. : Tissue oxygenation and hemodynamic response to NO synthase inhibition in septic shock. Shock 14 : 35-40, 2000
 
19) Seguin P, Bellissant E, Le Tulzo Y, et al. : Effect of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock. Clin Pharmacol Ther 71 : 381-388, 2002
PubMed
20) Levi M, Cate H, von der Poll T, et al. : Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 270 : 975-979, 1993
 
21) Joudain M, Tournoys A, Leroy X, et al. : Effects of Nω-nitro-L-arginine methy ester on the endotoxin-induced disseminated intravascular coaguration in porcine septic shock. Crit Care Med 25 : 452-459, 1997
 
22) Bune AJ, Brand MP, Heales SJR, et al. : Inhibition of tetrahydrobiopterin synthesis reduces in vivo nitric oxide production in experimental endotoxic shock. Biochem Biophys Res Comm 220 : 13-19, 1996
 
23) Perrella MA, Hsieh CM, Lee WS, et al. : Arrest of endotoxin-induced hypotension by transforming growth factorβ1. Proc Natl Acad Sci USA 93 : 2054-2059, 1990
 
24) Sanderson N, Facton V, Nagy P, et al. : Hepatic expression of mature transforming growth factorβ1 in transgenic mice results in multiple tissue lesions. Proc Nalt Acad Sci USA 92 : 2572-2576, 1995
 
25) Chiao H, Foster S, Thomas R, et al. : α-Melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. J Clin Invest 97 : 2038-2044, 1996
 
P.162 掲載の参考文献
1) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference : definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20 : 864-874, 1992
PubMed
2) Bone RC, Grodzin CJ, Balk RA : Sepsis : a new hypothesis for pathogenesis of the disease process. Chest 112 : 235-243, 1997
PubMed
3) Cohen J : The immunopathogenesis of sepsis. Nature 420 : 885-891, 2002
PubMed
4) Johnson D, Mayers I : Multiple organ dysfunction syndrome : anarrative review. Can J Anaesth 48 : 502-509, 2001
 
5) Schwertschlag US, Trepicchio WL, Dykstra KH, et al. : Hematopoietic, immunomodulatory and epithelial effects of interleukin-11. Leukemia 13 : 1307-1315, 1999
PubMed
6) Du X, Williams DA : Interleukin-11 : review of molecular, cell biology, and clinical use. Blood 89 : 3897-3908, 1997
PubMed
7) Paul SR, Bennett F, Calvetti JA, et al. : Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci USA 87 : 7512-7516, 1990
PubMed
8) McKinley D, Wu Q, Yang-Feng T, et al. : Genomic sequence and chromosomal location of human interleukin -11 gene (IL 11). Genomics 13 : 814-819, 1992
 
9) Czupryn M, Bennett F, Dube J, et al. : Alanine-scanning mutagenesis of human interleukin-11 : identification of regions important for biological activity. Ann N Y Acad Sci 762 : 152-164, 1995
PubMed
10) Sitaraman SV, Gewirtz AT : Oprelvekin. Genetics Institute. Curr Opin Investig Drugs 2 : 1395-1400, 2001
PubMed
11) Ellis M Zwaan F Hedstrom U et al. : Recombinant human interleukin 11 and bacterial infection in patients with haemological malignant disease undergoing chemotherapy : a double-blind placebo-controlled randomised trial. Lancet 361 : 275-280, 2003
 
12) Peterson RL, Wang L, Albert L, et al. : Molecular effects of recombinant human interleukin-11 in the HLA-B 27 rat model of inflammatory bowel disease. Lab Invest 78 : 1503-1512, 1998
 
13) Redlich CA, Gao X, Rockwell S, et al. : IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. J Immunol 157 : 1705-1710, 1996
PubMed
14) Opal SM, Jhung JW, Keith JC Jr, et al. : Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis. Blood 93 : 3467-3472, 1999
PubMed
15) Trepicchio WL, Wang L, Bozza M, et al. : IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB. J Immunol 159 : 5661-5670, 1997
PubMed
16) Trepicchio WL, Bozza M, Pedneault G, et al. : Recombinant human IL-1 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J Immunol 157 : 3627-3634, 1996
PubMed
17) Szabo G, Romics L Jr, Frendl G : Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis 6 : 1045-1066 x, 2002
PubMed
18) Fukuda Y, Sassa S : Effect of interleukin-11 On the levels of mRNAs encoding heme oxygenase and haptoglobin in human HepG 2 hepatoma cells. Biochem Biophys Res Commun 193 : 297-302, 1993
 
19) Herbert V, Shaw S, Jayatilleke E, et al. : Most free-radical injury is iron-related : it is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin. Stem Cells 12 : 289-303, 1994
PubMed
20) Otterbein LE, Choi AM : Heme oxygenase : colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 279 : L1029-1037, 2000
PubMed
21) Otterbein LE, Bach FH, Alam J, et al. : Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6 : 422-428, 2000
PubMed
22) Brouard S, Otterbein LE, Anrather J, et al. : Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192 : 1015-1026, 2000
PubMed
23) Stocker R, Yamamoto Y, McDonagh AF, et al. : Bilirubin is an antioxidant of possible physiological importance. Science 235 : 1043-1046, 1987
PubMed
24) Shimizu H, Takahashi T, Suzuki T, et al. : Protective effect of heme oxygenase induction in ischemic acute renal failure. Crit Care Med 28 : 809-817, 2000
PubMed
25) Odaka Y, Takahashi T, Yamasaki A, et al. : Prevention of halothane-induced hepatotoxicity by hemin pretreatment : protective role of heme oxygenase-1 induction. Biochem Pharmacol 59 : 871-880, 2000
PubMed
26) Toda N, Takahashi T, Mizobuchi S, et al. : Tin chloride pretreatment prevents renal injury in rats with ischemic acute renal failure. Crit Care Med 30 : 1512-1522, 2002
PubMed
27) Sheridan BC, Dinarello CA, Meldrum DR, et al. : Interleukin-11 attenuates pulmonary inflammation and vasomotor dysfunction in endotoxin-induced lung injury. Am J physiol 277 : L861-867, 1999
PubMed
28) Bozza M, Bliss JL, Maylor R, et al. : Interleukin-11 reduces T-cell-dependent experimental liver injury in mice. Hepatology 30 : 1441-1447, 1999
PubMed
29) Trepicchio WL, Bozza M, Bouchard P, et al. : Protective effect of rhIL-11 in a murine model of acetaminophen-induced hepatotoxicity. Toxicol Pathol 29 : 242-249, 2001
 
30) Suzuki T, Takahashi T, Yamasaki A, et al. : Tissue-specific gene expression of heme oxygenase-1 (HO-1) and non-specific deltaaminolevulinate synthase (ALAS-N) in a rat model of septic multiple organ dysfunction syndrome. Biochem Pharmacol 60 : 275-283, 2000
 
31) Ikejima K, Iimuro Y, Forman DT, et al. : A diet containing glycine improves survival in endotoxin shock in the rat. Am J Physiol 271 : G97-103, 1996
PubMed
32) Dominguez Fernandez E, Flohe S, Siemers F, et al. : Endotoxin tolerance in rats : influence on LPS-induced changes in excretory liver function. Inflamm Res 51 : 500-505, 2002
PubMed
33) Sass G, Koerber K, Bang R, et al. : Inducible nitric oxide synthase is critical for immunemediated liver injury in mice. J Clin Invest 107 : 439-447, 2001
PubMed
34) Laskin DL, Rodriguez del Valle M, Heck DE, et al. : Hepatic nitric oxide production following acute endotoxemia in rats is mediated by increased inducible nitric oxide synthase gene expression. Hepatology 22 : 223-234, 1995
PubMed
P.168 掲載の参考文献
1) Faure E, Thomas L, Xu H, et a1. : Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells. J Immunol 166 : 2018-2024, 2001
 
2) Kopp EB, R Medzhitov : The Toll-receptor family and control of innate immunity. Curr Opin Immunol 11 : 13-18, 1999
 
3) Schwandner R, Dziarski R, Wesche H, et al. : Peptidoglycan-and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 274, 17406-17409, 1999
PubMed
4) Dybdahl B, Wahba A, Lien E, et al. : Inflammatory response after open heart surgery : release of heat-shock protein 70 and signaling through toll-like receptor-4. Circulation 105 : 685-690, 2002
PubMed
5) Schiotz Thorud HM, Wisloff U, Lunde PK, et al. : Surgical manipulation, but not moderate exercise, is associated with increased cytokine mRNA expression in the rat soleus muscle. Acta Physiol Scand 175, 219-226, 2002
 
6) Vabulas RM, Ahmad-Nejad P, da Costa C, et al. : Endocytosed HSP 60 s use toll-like receptor 2 (TLR 2) and TLR 4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 276 : 31332-31339, 2001
 
7) Ono S, Aosasa S, Tsujimoto H, et al. : Increased monocyte activation in elderly patients after surgical stress. Eur Surg Res 33 : 33-38, 2001
PubMed
8) Ertel W, Kremer JP, Kenney J, et al. : Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85 : 1341-1347, 1995
PubMed
9) Kimura Y, Yaegashi Y, Sato N : Tumor necrosis factor-alpha production after esophageal cancer surgery : differences in the response to lipopolysaccharide stimulation among whole blood, pleural effusion cells, and bronchoalveolar lavage fluid cells. Surg Today 29 : 10-15, 1999
PubMed
10) Aosasa S, Ono S, Mochizuki H, et al. : Activation of monocytes and endothelial cells depends on the severity of surgical stress. World J Surg 24 : 10-16, 2000
PubMed
11) Ohki K, Amano F, Yamamoto S, et al. : Suppressive effects of serum on the LPS-induced production of nitric oxide and TNF-alpha by amacrophage-like cell line, WEHI-3, are dependent on the structure of polysaccharide chains in LPS. Immunol Cell Biol 77 : 143-152, 1999
 
12) Ozinsky A, Underhill DM, Fontenot JD, et al. : The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 97 : 13766-13771, 2000
PubMed
13) Beutler B, Beutler E : Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347 : 1978-1980, 2002
PubMed
14) Morre SA, Murillo LS, Bruggeman CA, et al. : The role that the functional Asp 299 Gly polymorphism in the toll-like receptor-4 gene plays in susceptibility to Chlamydia trachomatis-associated tubal infertility. J Infect Dis 187 : 341-342, 2003
 
15) PhilipPart F, Charpentier J, Mira Jp : Genetic susceptibility to infections. Rev Mal Respir 19 : 411-414, 2002
 
16) Lorenz E, Mira Jp, Frees KL, et al. : Relevance of mutations in the TLR 4 receptor in patients with gram-negative septic shock. Arch Intern Med 162 : 1028-1032, 2002
 

書評

最近チェックした商品履歴

Loading...